DE3578177D1 - 4,7-dihydropyrazolo(3,4-b)pyridin-derivate. - Google Patents

4,7-dihydropyrazolo(3,4-b)pyridin-derivate.

Info

Publication number
DE3578177D1
DE3578177D1 DE8585103017T DE3578177T DE3578177D1 DE 3578177 D1 DE3578177 D1 DE 3578177D1 DE 8585103017 T DE8585103017 T DE 8585103017T DE 3578177 T DE3578177 T DE 3578177T DE 3578177 D1 DE3578177 D1 DE 3578177D1
Authority
DE
Germany
Prior art keywords
dihydropyrazolo
pyridine derivatives
pyridine
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8585103017T
Other languages
German (de)
English (en)
Inventor
Ikuo Adachi
Teruo Yamamori
Motohiko Ueda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shionogi and Co Ltd
Original Assignee
Shionogi and Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi and Co Ltd filed Critical Shionogi and Co Ltd
Application granted granted Critical
Publication of DE3578177D1 publication Critical patent/DE3578177D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE8585103017T 1984-03-19 1985-03-15 4,7-dihydropyrazolo(3,4-b)pyridin-derivate. Expired - Fee Related DE3578177D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP59053118A JPS60197685A (ja) 1984-03-19 1984-03-19 ４，７―ジヒドロピラゾロ［３，４―ｂ］ピリジン誘導体とその製造法

Publications (1)

Publication Number Publication Date
DE3578177D1 true DE3578177D1 (de) 1990-07-19

Family

ID=12933883

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8585103017T Expired - Fee Related DE3578177D1 (de) 1984-03-19 1985-03-15 4,7-dihydropyrazolo(3,4-b)pyridin-derivate.

Country Status (8)

Country Link
EP (1) EP0157260B1 (enExample)
JP (1) JPS60197685A (enExample)
KR (1) KR910006646B1 (enExample)
AU (1) AU575134B2 (enExample)
DE (1) DE3578177D1 (enExample)
DK (1) DK122385A (enExample)
ES (1) ES8602787A1 (enExample)
GB (1) GB2156348B (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6056979A (ja) * 1983-09-08 1985-04-02 Shionogi & Co Ltd ４，７−ジヒドロピラゾロ〔３，４−ｂ〕ピリジン誘導体およびその製造法
US6977262B2 (en) 2001-02-02 2005-12-20 Mitsubishi Pharma Corporation Dihydropyrazolopyridine compounds and pharmaceutical use thereof
KR20030076650A (ko) * 2001-02-02 2003-09-26 미쯔비시 웰 파마 가부시키가이샤 디하이드로피라졸로피리딘 화합물 및 그의 약학적 용도

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3403158A (en) * 1966-03-11 1968-09-24 Upjohn Co 1h-pyrazolo[3, 4-b]pyridines
DE1670827C3 (de) * 1967-03-20 1974-10-24 Bayer Ag, 5090 Leverkusen 4-(2'-Nitrophenyl)-2,6-dimethyl-3,5-dicarbmethoxy-1,4-dihydropyridin
US4038283A (en) * 1975-04-30 1977-07-26 E. R. Squibb & Sons, Inc. 4-Alkoxy or hydroxy derivatives of 2H-pyrazolo[3,4-b]pyridine-5-carboxylic acids and esters
US3985757A (en) * 1975-09-17 1976-10-12 E. R. Squibb & Sons, Inc. Pyrazolopyridine ketones
CH635840A5 (en) * 1978-01-01 1983-04-29 Thomae Gmbh Dr K 1H-Pyrazolo[3,4-b]pyridines
JPS5965089A (ja) * 1982-10-05 1984-04-13 Shionogi & Co Ltd ジヒドロピラゾロ〔３，４−ｂ〕ピリジン誘導体およびその製造法
GR79111B (enExample) * 1982-12-20 1984-10-02 Lepetit Spa

Also Published As

Publication number Publication date
KR910006646B1 (ko) 1991-08-30
GB2156348A (en) 1985-10-09
KR850006406A (ko) 1985-10-05
JPS60197685A (ja) 1985-10-07
ES541910A0 (es) 1985-12-01
GB2156348B (en) 1988-05-05
EP0157260B1 (en) 1990-06-13
AU4007085A (en) 1985-09-26
EP0157260A1 (en) 1985-10-09
JPH0437834B2 (enExample) 1992-06-22
ES8602787A1 (es) 1985-12-01
DK122385D0 (da) 1985-03-18
DK122385A (da) 1985-09-20
GB8507008D0 (en) 1985-04-24
AU575134B2 (en) 1988-07-21

Similar Documents

Publication Publication Date Title
FI843001A7 (fi) Pyrrolo(1,2-a)imidazol- och imidatzo (1,2-a)pyridinimmunomodulatorer.
FI861262A7 (fi) 5- 5-(6-imidazo(1,2-a)pyridyl)pyridinderivativ.
FI850275A0 (fi) Nya 6-susbtituerade furo-(3,4-c) -pyridinderivat.
FI841273L (fi) Foerfarande foer framstaellning av nya furo-(3,4-c)-pyridinderivater.
FI831437A7 (fi) 2-fenyyli-imidatso/4,5-c/pyridiinejä.
DE3576691D1 (de) Tricyclische pyridonderivate.
ATE33651T1 (de) Imidazo(1,5-a)pyridin-derivate.
FI893605A0 (fi) Imidatso (4,5-b) pyridinderivat.
GB2128186B (en) Dihydropyrazolo(3,4-b)pyridine derivatives
FI864891A7 (fi) Foerfarande foer framstaellning av 6,7,8,9-tetrahydro-10-metylpyrido/1,2-a/indol-9-aminer och deras derivat.
DE3485040D1 (de) (1) benzepino(3,4-b)pyridin-derivate.
FI834664A7 (fi) Substituoidut imidatso(1,5-a)pyridiinit.
DE3575304D1 (de) Alkynylderivatevon pyrazolo-(3,4-b)-pyridinlactamen.
DE3682244D1 (de) Substituierte dihydroimidazo(1,2-a)chinoxalinderivate.
FI864003A7 (fi) Pyrido /1,2-a/ pyrimidinderivat, foerfaranden foer framstaellning daerav och dessa innehaollande farmaceutiska kompositioner foer behandling av allergiska sjukdomar.
DE3267918D1 (de) Pyrazolo(3,4-b)pyridine derivatives
FI854180A0 (fi) Foerfarande foer framstaellning av nya 6-fenetylaminoalkyl-furo-(3,4-c)-pyridinderivat.
FI870254A7 (fi) Foerfarande foer framstaellning av 3-acylaminometylimidazo/1,2-a/pyridiner.
AU575134B2 (en) 4,7-dihydropyrazolo (3,4-b) pyridine derivatives
FI874400A7 (fi) Foerfarande foer framstaellning av imidazo-4,5-b pyridin-2-on-derivat.
DE3766518D1 (de) Substituierte 1,3,4,9-tetrahydropyrano(3,4-b)indol-1-acetate.
GB8421763D0 (en) 4,7-dihydropyrazolo (3,4-b) pyridine derivatives
FI840088A7 (fi) Foerfarande foer framstaellning av substituerade karboxi-tiazolo (3,2-a)pyrimidinderivat.
FI865344A7 (fi) Foerfarande foer framstaellning av pyrimido/5,4-b//1,4/oxazinderivat.
DE3585128D1 (de) 2-phenylpyrano(2,3-b)pyridine.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee